In The News Posted March 4, 2022 Share Posted March 4, 2022 SEATTLE, 4 mars 2022 /PRNewswire/ -- LumiThera Inc., une société de dispositifs médicaux au stade de commercialisation offrant un traitement par photobiomodulation (PBM) pour les lésions et les maladies oculaires, a annoncé aujourd'hui la finalisation de l'acquisition de Diopsys, Inc.. Il...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now